Occurrence and elimination of pharmaceuticals and personal care products in wastewater treatment plants. A literature review;Le devenir des résidus pharmaceutiques dans les stations d'épuration d'eaux usées: Une synthèse de la littérature

Techniques - Sciences - Methodes

Volumn , Issue 11, 2009, Pages 75-94

  Miege C ^a   Choubert, J M ^a   Ribeiro, L ^a   Eusebe M ^a   Coquery, M ^a  

^a CEMAGREF   (France)

Author keywords

Activated sludge; Database; Personal care products; Pharmaceuticals; Removal efficiency; Wastewater treatment plants

Indexed keywords

BIOACTIVITY; BIOCHEMICAL OXYGEN DEMAND; BIOLOGICAL WATER TREATMENT; BIOREACTORS; DATABASE SYSTEMS; EFFLUENTS; REMOVAL; SEWAGE PUMPING PLANTS; SEWAGE TREATMENT PLANTS; WASTEWATER; WASTEWATER RECLAMATION; WATER RECYCLING; WATER TREATMENT PLANTS;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENTS; LITERATURE REVIEWS; MEMBRANE BIOREACTOR; NITROGEN TREATMENT; PERSONAL CARE PRODUCTS; PHARMACEUTICALS AND PERSONAL CARE PRODUCTS; QUANTITATIVE VALUES; REMOVAL EFFICIENCIES; SCIENTIFIC PUBLICATIONS; WASTEWATER TREATMENT PLANTS;

WASTEWATER TREATMENT;

ACTIVATED SLUDGE; BIOREACTOR; DATABASE; DRUG; POLLUTANT REMOVAL; WASTE FACILITY; WASTE TREATMENT; WASTEWATER;

EID: 72049086958     PISSN: 02997258     EISSN: None     Source Type: Journal    
DOI: 10.1051/tsm/200911075     Document Type: Review

References (21)

1. CURA M., STRENN B., GANS O., MARTINEZ E., KREUZINGER N., KROISS H. (2005) : « Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants ». Water Research, 39:4797-4807.
2. DAUGHTON C.G., TERNES T.A. (1999): « Pharmaceuticals and personal care products in the environment: Agents of subtle change? ». Environmental Health Perspectives, 107 supplement 6:907-938.
3. DIRECTIVE EUROPÉENNE 91/271/CEE (1991) relative aux traitements des eaux résiduaires urbaines. Journal officiel de la Communauté européenne. http://admi.net/eur/loi/leg-euro/fr-391L0271.html (le 18 décembre 2008).
4. DÉCRET D'APPLICATION 94-469 du 3 JUIN 1994 (1994) relatif à la collecte et au traitement des eaux usées mentionnées aux articles L 372-1-1 et L 371-373 du code des communes. ENVE9420024D. 7 p. www.legifrance.gouv.fr (le 18 décembre 2008).
5. 5. DEVO0754085A. 25 p. www.legifrance.gouv.fr/affich- Texte.do?cidTexte=JORFTEXT000000276647&dateTexte (le 18 décembre 2008).
6. FENT K., WESTON A.A., CAMINADA D. (2006): « Ecotoxicology of human pharmaceuticals ».Aquatic Toxicology, 76:122-159.
7. GARRIC J., FERRARI B. (2005): « Les substances pharmaceutiques dans les milieux aquatiques. Niveaux d'exposition et effet biologique: que savons-nous ? ». Revue des Sciences de l'Eau, 18:307-330.
8. HALLING-SORENSEN B., NIELSEN S.N., UNZKY P.F., INGERSLEV F., LUTZHOFT H.C.H., JORGENSEN S.E. (1998): « Occurrence, fate and effects of pharmaceutical substances in the environment - A review ». Chemosphere, 36:357-394.
9. HEBERER T. (2002): « Occurrence, fate, and removal of pharmaceutical residues in the aquatic environment: A review of recent research data ». Toxicology Letters, 131:5-17.
10. HENZE M., HARREMOËS P., LA COUR JANSEN J., ARVIN A. (1996): Wastewater Treatment. Biological and Chemical processes. Springler-Verlag, 383 p.
11. JANEX-HABIBI M.L., BRUCHET A., TERNES T.A. (2004): « Effet des traitements d'eau potable et d'épuration des eaux usées sur les résidus médicamenteux. Résultats du projet Poséidon ». TSM, 11: 59-67.
12. JONES A.H., VOULVOULIS N., LESTER J.N. (2004): « Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment ». Critical Reviews in Toxicology, 34: 335-350.
13. JORGENSEN S.E., HALLING-SORENSEN B. (2000): « Drugs in the environment ». Chemosphere, 40:691-699.
14. KUMMERER K. (2001): « Drugs in the environment: Emission of drugs, diagnostic aids and disinfectants into wastewater by hospitals in relation to other sources - A review ». Chemosphere, 45:957-969.
15. KUSTER M., JOSE LOPEZ DE ALDA M., BARCELO D. (2004): « Analysis and distribution of estrogens and progestogens in sewage sludge, soils and sediments ». Trends in Analytical Chemistry, 23:790-798.
16. LARSEN T.A., LIENERT J., JOSS A., SIEGRIST H. (2004 « How to avoid pharmaceuticals in the aquatic environment ». Journal of Biotechnology, 113:295-304. (Pubitemid 39237085)
17. MIÈGE C. CHOUBERT J.M., RIBEIRO L., EUSÈBE M., COQUERY M. (2009): « Fate of pharmaceuticals and personal care products in wastewater treatment plants - Conception of a database and first results ». Environmental Pollution 157: 1721-1726.
18. PETROVIC M., GONZALEZ S., BARCELO D. (2003): « Analysis and removal of emerging contaminants in wastewater and drinking water ». Trends in Analytical Chemistry, 22:685-696. (Pubitemid 37509935)
19. TERNES T.A., BONERZ M., SCHMIDT T. (2001): « Determination of neutral pharmaceuticals in wastewater and rivers by liquid chromatography- electrospray tandem mass spectrometry ». Journal of Chromatography A, 938:175-185. (Pubitemid 33145463)
20. ZUCCATO E., CASTIGLIONI S., FANELLI R., REITANO G., BAGNATI R., CHIABRANDO C., et al. (2006): « Pharmaceuticals in the environment in Italy: Causes, occurrence, effects and control ». Environmental Science and Pollution Research, 13:15-21.
21. ZWIENER C., FRIMMEL F.H. (2004): « LC-MS analysis in the aquatic environment and in water treatment technology a critical review - Part II: Applications for emerging contaminants and related pollutants, microorganisms and humic acids ». Analytical and Bioanalytical Chemistry, 378: 862-874.